Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

Bob Chandler launches new healthcare comms ‘micro-network’

Members of Watershed Bridges include wethepeople, BK Digital and MaxAscent

- PMLiVE

Pfizer/Opko’s long-acting growth hormone misses mark in trial

Previously forecast as a blockbuster product, hGH-CTP fails to show significant change

Biogen Idec building

FDA approves Biogen’s Spinraza for spinal muscular atrophy

Analysts predict blockbuster sales as drug is priced at $750,000 for first year of treatment

- PMLiVE

Behavioural marketing and its effectiveness

Marketing effectiveness is about changing behaviour. Only by understanding customer behaviour can we begin to change it.

Key accounts – origins, responsibilities and differences

Good key account managers will know more about their account status than their customers do

- PMLiVE

Ashfield Clinical appoints Nagore Fernandez Dominguez

She takes up role as head of clinical services for Europe

OncoMed’s CMO steps down

Dr Jakob Dupont to leave the clinical-stage company

- PMLiVE

What’s on the horizon?

The evolving role of the healthcare expert.

- PMLiVE

Teva hit with largest-ever fine under US anti-corruption act

Company to pay $519m after promoting Copaxone in Russia, Ukraine and Mexico

Roche Basel Switzerland

Roche’s haemophilia A drug hits targets in registration trial

Emicizumab from Japanese affiliate Chugai cleared a phase III trial

- PMLiVE

A healthy challenge

The EC’s Dr Vytenis Andriukaitis on Europe’s problems with health

Alexion Pharmaceutiacal names interim CEO and CFO

Former AZ CEO David Brennan and David Anderson join

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links